Since the beginning of Chair Khan’s tenure at the Federal Trade Commission (and in line with President Biden’s aim to curb rising health care costs), the current FTC has committed to bring enforcement actions against health...more
On July 25, 2022, the Antitrust Division of the U.S. Department of Justice (“DOJ”) filed a civil complaint in the U.S. District Court for the District of Maryland alleging that poultry processors, Cargill Inc. and Cargill...more
8/3/2022
/ Anti-Competitive ,
Civil Conspiracy ,
Compensation ,
Consent Decrees ,
Department of Justice (DOJ) ,
Employee Benefits ,
Meat Processing Plants ,
Poultry ,
Price-Fixing ,
Sensitive Business Information ,
Sherman Act ,
Trade Associations ,
Wage and Hour
On June 11, 2021, the U.S. Court of Appeals for the Second Circuit dismissed the Federal Trade Commission’s (FTC) administrative order against 1-800 Contacts, Inc. The Second Circuit found that the online retailer’s trademark...more
In the latest decision addressing antitrust liability for FRAND commitments, Judge Barbara M. G. Lynn of the Northern District of Texas dismissed a complaint from Continental Automotive Systems, Inc. (“Continental”) alleging,...more
9/18/2020
/ Anti-Competitive ,
Antitrust Violations ,
Bargaining Power ,
Breach of Contract ,
Declaratory Judgments ,
Department of Justice (DOJ) ,
Dismissal With Prejudice ,
Failure To State A Claim ,
Federal Trade Commission (FTC) ,
FRAND ,
Monopolization ,
Motion to Transfer ,
Patent Infringement ,
Patents ,
Sherman Act ,
Standard Essential Patents ,
Standing ,
Subject Matter Jurisdiction ,
Supplemental Jurisdiction ,
Unfair Competition Law (UCL)
Last Thursday, September 10, 2020, the U.S. Department of Justice’s Antitrust Division (“DOJ”) issued an updated Business Review Letter (“2020 Letter”) to the Institute of Electrical Electronics Engineers, Incorporated...more
In a recent decision in In Re Humira (Adalimumab) Antitrust Litigation, No. 19-cv-1873, Judge Shah of the Northern District of Illinois dismissed a consolidated class action complaint filed by U.S. purchasers of AbbVie Inc.’s...more
6/22/2020
/ Anti-Competitive ,
Antitrust Injuries ,
Antitrust Litigation ,
Biopharmaceutical ,
Biosimilars ,
BPCIA ,
Class Action ,
Monopolization ,
Noerr-Pennington Doctrine ,
Patent Dance ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Sherman Act ,
USPTO